Does DOLUTEGRAVIR Cause Benign prostatic hyperplasia? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Benign prostatic hyperplasia have been filed in association with DOLUTEGRAVIR (Juluca). This represents 0.2% of all adverse event reports for DOLUTEGRAVIR.
18
Reports of Benign prostatic hyperplasia with DOLUTEGRAVIR
0.2%
of all DOLUTEGRAVIR reports
0
Deaths
7
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From DOLUTEGRAVIR?
Of the 18 reports, 7 (38.9%) required hospitalization.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOLUTEGRAVIR. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does DOLUTEGRAVIR Cause?
Foetal exposure during pregnancy (1,036)
Exposure during pregnancy (776)
Virologic failure (770)
Pathogen resistance (586)
Maternal exposure during pregnancy (517)
Viral mutation identified (510)
Treatment failure (453)
Drug ineffective (447)
Off label use (413)
Blood hiv rna increased (410)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which DOLUTEGRAVIR Alternatives Have Lower Benign prostatic hyperplasia Risk?
DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE
DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL
DOLUTEGRAVIR vs DOLUTEGRAVIR\RILPIVIRINE
DOLUTEGRAVIR vs DOMPERIDONE
DOLUTEGRAVIR vs DOMPERIDONE\PANTOPRAZOLE